Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma

OBJECTIVE: This prospective, observational, postmarketing surveillance was conducted to evaluate the safety and effectiveness of mogamulizumab, an anti‐CC chemokine receptor 4 (CCR4) monoclonal antibody, in patients with CCR4‐positive, relapsed or refractory (r/r) adult T‐cell leukemia‐lymphoma (ATL...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Haematol
Main Authors: Ishitsuka, Kenji, Yurimoto, Satoshi, Tsuji, Yukie, Iwabuchi, Manabu, Takahashi, Takeshi, Tobinai, Kensei
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850465/
https://ncbi.nlm.nih.gov/pubmed/30740787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13220
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki